LWA
CTSO icon

Ledgewood Wealth Advisors’s Cytosorbents Corp CTSO Stock Holding History

Ledgewood Wealth Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-73,000
Closed -$81K – 62
2023
Q4 		$81K Buy
+73,000
New +$108K 0.07% 57

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Ledgewood Wealth Advisors's CTSO Position: Q1 2024 in Review

Ledgewood Wealth Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2024, closing a stake of 73,000 shares — an estimated $81K sold.

Ledgewood Wealth Advisors first reported a position in CTSO in Q4 2023 and held it in 1 quarter. The position peaked at $81K in Q4 2023. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2024.

  • Ledgewood Wealth Advisors reported no remaining Cytosorbents Corp position as of Q1 2024 after selling out during the quarter.
  • Ledgewood Wealth Advisors sold 73,000 Cytosorbents Corp shares in Q1 2024, an estimated $81K.
  • Ledgewood Wealth Advisors first reported a position in Cytosorbents Corp in Q4 2023 and held it in 1 quarter.
  • Ledgewood Wealth Advisors's Cytosorbents Corp position peaked at $81K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2024.

Based on Ledgewood Wealth Advisors's 13F filing for Q1 2024, filed 15 Apr 2025.